LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
STLA
Stellantis N.V.
There isn't enough reported data to score STLA yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
STLA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Strong |
STLA's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
STLA PE Valuation
STLA has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
STLA Forward outlook
There aren't enough analyst estimates for STLA to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the stronger earnings trend. Trailing diluted EPS is down 224% for LCID versus STLA down 348%.
STLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2020 | -$0.37 | -108% |
| Q3 2020 | -$0.01 | -100% |
| Q2 2020 | -$0.98 | -119% |
| Q1 2020 | $3.05 | +34% |
| Q4 2019 | $4.69 | +82% |
| Q3 2019 | $4.51 | +103% |
| Q2 2019 | $5.03 | +104% |
| Q1 2019 | $2.28 | -17% |
STLA has swung to a loss: it lost $7.55 per share over the past year, after a profit the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the stronger quarterly revenue trend. Revenue is up 4.1% for LCID versus down 49% for STLA.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
STLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $90.7B | +9.9% |
| Q4 2025 | $88B | +10% |
| Q2 2025 | $82.5B | -13% |
| Q4 2024 | $79.8B | -21% |
| Q2 2024 | $94.4B | -14% |
| Q4 2023 | $101.3B | -0.5% |
| Q2 2023 | $109.3B | +12% |
| Q4 2020 | $31.8B | -3.6% |
STLA's revenue has slid since its 2023 peak: $41.8B last quarter, down 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.6% | +1.5 points |
| Q2 2026 | 1.7% | +5 points |
| Q4 2025 | -26% | -36 points |
| Q2 2025 | -2.1% | -16 points |
| Q4 2024 | -3.3% | -14 points |
| Q2 2024 | 9.2% | N/A |
| Q4 2023 | 10% | -2.5 points |
| Q2 2023 | 14% | N/A |
STLA has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has the stronger cash trend. Its trailing FCF is down 75% versus its history, compared with STLA at down 1,065%.
STLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.8B | +$6.5B |
| Q4 2025 | -$4.8B | +$2.1B |
| Q2 2025 | -$8.3B | -$6.3B |
| Q4 2024 | -$6.9B | -286% |
| Q2 2024 | -$1.9B | -119% |
| Q4 2023 | $3.7B | -39% |
| Q4 2020 | $4.3B | +164% |
| Q3 2020 | $7.5B | +3430% |
STLA has burned cash in six of the last eight quarters: −$21.2B over the past year, against $4.8B the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
STLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -7.3M shares |
| 1 year | +0.7% | +19.5M shares |
| 3 years | +84% | +1.3B shares |
| 5 years | +85% | +1.3B shares |
| Available history | +86% | +1.3B shares |
STLA has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q4 2025 | — |
| Q2 2025 | — |
| Q4 2024 | $1.1B |
| Q2 2024 | $2.2B |
| Q4 2023 | $2B |
| Q2 2023 | $748.7M |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
STLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2020 | -0.4x | Net Cash |
| Q3 2020 | 0.1x | Very low |
| Q2 2020 | 1.1x | Healthy |
| Q1 2020 | 0.2x | Very low |
| Q4 2019 | -0.2x | Net Cash |
| Q3 2019 | -0.1x | Net Cash |
| Q2 2019 | -0.0x | Net Cash |
| Q1 2019 | 0.3x | Very low |
STLA has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
STLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.5 | Neutral |
| Stochastic | 19.3 | Oversold |
STLA's weekly RSI is 30 (neutral) and its Stochastic is 19 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
STLA PE vs Consumer Cyclical Sector
| Metric | STLA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
STLA has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
STLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.36 | 11% below |
| 20 week MA | $5.04 | 23% below |
| 50 week MA | $7.05 | 45% below |
| 100 week MA | $8.90 | 57% below |
| 200 week MA | $14.0 | 72% below |
STLA is in a downtrend: it's below all five of its weekly moving averages, and 72% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
STLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.9 | $17.7 | +19% |
| 2021 | $17.7 | $18.8 | +6.2% |
| 2022 | $18.8 | $14.1 | -25% |
| 2023 | $14.1 | $23.3 | +66% |
| 2024 | $23.3 | $13.1 | -44% |
| 2025 | $13.1 | $11.1 | -15% |
| 2026 YTD | $11.1 | $3.86 | -65% |
STLA has the edge over LCID on returns for 2026, with the stronger performance.